从药物发现的角度探索 SureChEMBL
Yojana Gadiya1,2,3, Simran Shetty4,5,6, Martin Hofmann-Apitius7,8
1Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Schnackenburgallee 114, 22525, Hamburg, Germany. Yojana.Gadiya@itmp.fraunhofer.de.
Scientific data
|May 16, 2024
概括
这项研究分析了SureChEMBL的专利数据,以确定潜在的候选药物. 我们评估药物相似性和开发阶段的化合物,帮助制药药物发现.
科学领域:
- 制药化学 制药化学 制药化学
- 药用化学 医学化学
- 药物发现信息学 药物发现信息学
背景情况:
- 药物开发是昂贵的,因此专利保护至关重要.
- 分析专利文件有助于确定新药候选者的操作自由.
- 公共存储库提供自动化方法来提取治疗剂信息.
研究的目的:
- 在SureChEMBL.中提供专利化合物的全面概述.
- 评估这些化合物对制药药物发现的重要性.
- 根据药物相似性和临床开发阶段来评估化合物.
主要方法:
- 探索了 SureChEMBL,这是一个生命科学公共专利数据库.
- 在公共化学数据资源中识别了专利化合物.
- 在专利文件中标点化学注释.
- 对药物相似性标准进行评估的化合物.
- 检查了临床成功的药物开发阶段.
主要成果:
- 从SureChEMBL数据库中对专利化合物进行了目录.
- 评估已识别的化合物的药物相似性和潜力.
- 分析了这些制药化合物的临床开发状态.
- 提供了关于SureChEMBL化合物的药物发现相关性的见解.
结论:
- SureChEMBL是识别生命科学中的专利化合物的宝贵资源.
- 该研究展示了从专利数据中评估候选药物潜力的方法.
- 这些发现有助于了解与制药药物发现相关的化合物的景观.
相关概念视频
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Structure-Activity Relationships and Drug Design
701
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
701
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Chirality in Nature
13.4K
Chirality is the most intriguing yet essential facet of nature, governing life’s biochemical processes and precision. It can be observed from a snail shell pattern in a macroscopic world to an amino acid, the minutest building block of life. Most of the snails around the world have right-coiled shells because of the intrinsic chirality in their genes. All the amino acids present in the human body exist in an enantiomerically pure state, except for glycine - the sole achiral amino acid.
13.4K


